Ranked #951 of 8,699 institutional investors
Kedalion Capital Management LLP
London, X0
$3.90B
US stock portfolio at live prices · today −$73.4M (−1.85%)
Live prices, last trade 11:46 AM ET
- Value at quarter end (Q3 2026)
- $4.24B
- Change from Q2 2026
- +$26.8M (+0.64%)
- Positions
- 3 · 1 new, 1 sold out
- Filed
- Nov 6, 2026
Not counted in the ranking: call options on $51.1M of stock. $508K of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesSPYM 95.3%IVV 4.70%ABUS <0.1%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| SPYM State Street SPDR Portfolio S&P 500 ETF | 44,970,000 | $3.72B | 95.3% | Added +28% |
| IVV iShares Core S&P 500 ETF | 260,000 | $183M | 4.70% | Reduced −83% |
| ABUS Arbutus Biopharma Corporation | 20,168 | $82K | <0.1% | New |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| BE Bloom Energy Corporation | 16,000 | $2.3M |